Advancing Drug Safety in Drug Development: Bridging Computational Predictions for Enhanced Toxicity Prediction
Open accessThe DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Abstract
The attrition rate of drugs in clinical trials is generally quite high, with estimates suggesting that approximately 90% of drugs fail to make it through the process. The identification of unexpected toxicity issues during preclinical stages is a significant factor contributing to this high rate of failure. These issues can have a major impact on the success of a drug and must be carefully considered throughout the development process. These late-stage rejections or withdrawals of drug candidates significantly increase the costs associated with drug development, particularly when toxicity is detected during clinical trials or after market release. Understanding drug-biological target interactions is essential for evaluating compound toxicity and safety, as well as predicting therapeutic effects and potential off-target effects that could lead to toxicity. This will enable scientists to predict and assess the safety profiles of drug candidates more accurately. Evaluation of toxicity and safety is a critical aspect of drug development, and biomolecules, particularly proteins, play vital roles in complex biological networks and often serve as targets for various chemicals. Therefore, a better understanding of these interactions is crucial for the advancement of drug development. The development of computational methods for evaluating protein-ligand interactions and predicting toxicity is emerging as a promising approach that adheres to the 3Rs principles (replace, reduce, and refine) and has garnered significant attention in recent years. In this review, we present a thorough examination of the latest breakthroughs in drug toxicity prediction, highlighting the significance of drug-target binding affinity in anticipating and mitigating possible adverse effects. In doing so, we aim to contribute to the development of more effective and secure drugs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Advancing drug safety assessment relies on bridging the translation gap between animal toxicology findings and clinical outcomes, a challenge with far-reaching consequences for R&D efficiency, regulatory success and patient safety (Waring et al., 2015; Amorim et al., 2024).”
From A large-scale concordance study of toxicity findings across preclinical species and humans for small molecules and biologics (2026) · cites this paper as Amorim et al., 2024
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
XGBoost: A Scalable Tree Boosting System
Chen, T., & Guestrin, C. (2016) · Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining · doi:10.1145/2939672.2939785 · Cited by 54,569 · cited 1×
“Using an ensemble approach that leverages DNN, RF, and extreme Gradient Boosting (XGBoost), 62 they also examined the contribution of each input fingerprint to the prediction output, thus gaining insight into warning substructures that might be indicative of the cardiotoxicity of the input compound.”
MethodDrugBank 5.0: a major update to the DrugBank database for 2018
Wishart, D. S., Feunang, Y. D., Guo, A. C., Lo, E. J., Marcu, A., Grant, J. R., Sajed, T., Johnson, D., Li, C., Sayeeda, Z., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1037 · Cited by 8,404
PubChem in 2021: new data content and improved web interfaces
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa971 · Cited by 3,953
Kim, S., Chen, J., Cheng, T., Gindulyte, A., He, J., He, S., Li, Q., Shoemaker, B. A., Thiessen, P. A., Yu, B., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkac956 · Cited by 3,443
Xiong, G., Wu, Z., Yi, J., Fu, L., Yang, Z., Hsieh, C., Yin, M., Zeng, X., Wu, C., Lu, A., et al. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab255 · Cited by 2,857
Comprehensive analysis of kinase inhibitor selectivity
Davis, M. I., Hunt, J. P., Herrgard, S., Ciceri, P., Wodicka, L. M., Pallares, G., Hocker, M., Treiber, D. K., & Zarrinkar, P. P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1990 · Cited by 2,409
Gaulton, A., Hersey, A., Nowotka, M., Bento, A. P., Chambers, J., Mendez, D., Mutowo, P., Atkinson, F., Bellis, L. J., Cibrián-Uhalte, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1074 · Cited by 2,330
KEGG for representation and analysis of molecular networks involving diseases and drugs
Kanehisa, M., Goto, S., Furumichi, M., Tanabe, M., & Hirakawa, M. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp896 · Cited by 2,322
SchNet – A deep learning architecture for molecules and materials
Schütt, K. T., Sauceda, H. E., Kindermans, P.-J., Tkatchenko, A., & Müller, K.-R. (2018) · The Journal of Chemical Physics · doi:10.1063/1.5019779 · Cited by 2,217
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
DeepDTA: deep drug–target binding affinity prediction
Öztürk, H., Özgür, A., & Ozkirimli, E. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty593 · Cited by 1,696
Artificial intelligence in drug discovery and development
Paul, D., Sanap, G., Shenoy, S., Kalyane, D., Kalia, K., & Tekade, R. K. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2020.10.010 · Cited by 1,695
STITCH 5: augmenting protein–chemical interaction networks with tissue and affinity data
Szklarczyk, D., Santos, A., von Mering, C., Jensen, L. J., Bork, P., & Kuhn, M. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1277 · Cited by 1,687
An Improved Bacterial Test System for the Detection and Classification of Mutagens and Carcinogens
Ames, B. N., Lee, F. D., & Durston, W. E. (1973) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.70.3.782 · Cited by 1,532
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
Wilkins, M. R., Sanchez, J.-C., Gooley, A. A., Appel, R. D., Humphery-Smith, I., Hochstrasser, D. F., & Williams, K. L. (1996) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.1996.10647923 · Cited by 1,331
GraphDTA: predicting drug–target binding affinity with graph neural networks
Nguyen, T., Le, H., Quinn, T. P., Nguyen, T., Le, T. D., & Venkatesh, S. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa921 · Cited by 1,220
Prediction of drug–target interaction networks from the integration of chemical and genomic spaces
Yamanishi, Y., Araki, M., Gutteridge, A., Honda, W., & Kanehisa, M. (2008) · Bioinformatics · doi:10.1093/bioinformatics/btn162 · Cited by 1,147
Gaussian interaction profile kernels for predicting drug–target interaction
van Laarhoven, T., Nabuurs, S. B., & Marchiori, E. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr500 · Cited by 934
On Some Aspects of Variable Selection for Partial Least Squares Regression Models
Roy, P. P., & Roy, K. (2008) · QSAR & Combinatorial Science · doi:10.1002/qsar.200710043 · Cited by 793
Limitations of Animal Studies for Predicting Toxicity in Clinical Trials
Van Norman, G. A. (2019) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2019.10.008 · Cited by 732
Lee, I., Keum, J., & Nam, H. (2019) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1007129 · Cited by 675
Overview of Therapeutic Drug Monitoring
Kang, J.-S., & Lee, M.-H. (2009) · The Korean journal of internal medicine · doi:10.3904/kjim.2009.24.1.1 · Cited by 669
Tang, J., Szwajda, A., Shakyawar, S., Xu, T., Hintsanen, P., Wennerberg, K., & Aittokallio, T. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci400709d · Cited by 645
Onakpoya, I. J., Heneghan, C. J., & Aronson, J. K. (2016) · BMC Medicine · doi:10.1186/s12916-016-0553-2 · Cited by 616
Chicco, D., & Jurman, G. (2023) · BioData Mining · doi:10.1186/s13040-023-00322-4 · Cited by 597
Molecular representations in AI-driven drug discovery: a review and practical guide
David, L., Thakkar, A., Mercado, R., & Engkvist, O. (2020) · Journal of Cheminformatics · doi:10.1186/s13321-020-00460-5 · Cited by 587 · cited 1×
“…are possible owing to advances in computational frameworks for retrieving relevant information from chemical structures and characteristics, 19 and a range of methodologies have been used to forecast toxicity, including different types of neural networks, quantitative structure activity…”
Toward more realistic drug-target interaction predictions
Pahikkala, T., Airola, A., Pietila, S., Shakyawar, S., Szwajda, A., Tang, J., & Aittokallio, T. (2015) · Briefings in Bioinformatics · doi:10.1093/bib/bbu010 · Cited by 559
Karimi, M., Wu, D., Wang, Z., & Shen, Y. (2019) · Bioinformatics · doi:10.1093/bioinformatics/btz111 · Cited by 536
Sager, J. E., Yu, J., Ragueneau-Majlessi, I., & Isoherranen, N. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.065920 · Cited by 518
He, T., Heidemeyer, M., Ban, F., Cherkasov, A., & Ester, M. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0209-z · Cited by 509
Forging the basis for developing protein-ligand interaction scoring functions.
Liu, Z., Su, M., Han, L., Liu, J., Yang, Q., Li, Y., & Wang, R. (2017) · Accounts of Chemical Research · doi:10.1021/acs.accounts.6b00491 · Cited by 493
Part 1: Simple Definition and Calculation of Accuracy, Sensitivity and Specificity.
Baratloo, A., Hosseini, M., Negida, A., & Ashal, G. E. (2015) · Archives of Academic Emergency Medicine · doi:10.22037/aaem.v3i2.264 · Cited by 454
Machine learning approaches and databases for prediction of drug–target interaction: a survey paper
Bagherian, M., Sabeti, E., Wang, K., Sartor, M. A., Nikolovska-Coleska, Z., & Najarian, K. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbz157 · Cited by 429
Mechanisms of Drug Toxicity and Relevance to Pharmaceutical Development
Guengerich, F. P. (2011) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.dmpk-10-rv-062 · Cited by 387
Drug–target affinity prediction using graph neural network and contact maps
Jiang, M., Li, Z., Zhang, S., Wang, S., Wang, X., Yuan, Q., & Wei, Z. (2020) · RSC Advances · doi:10.1039/d0ra02297g · Cited by 372
Why animal studies are often poor predictors of human reactions to exposure
Bracken, M. B. (2009) · Journal of the Royal Society of Medicine · doi:10.1258/jrsm.2008.08k033 · Cited by 362
Lenselink, E. B., ten Dijke, N., Bongers, B., Papadatos, G., van Vlijmen, H. W. T., Kowalczyk, W., IJzerman, A. P., & van Westen, G. J. P. (2017) · Journal of Cheminformatics · doi:10.1186/s13321-017-0232-0 · Cited by 334
Binding MOAD (Mother Of All Databases)
Hu, L., Benson, M. L., Smith, R. D., Lerner, M. G., & Carlson, H. A. (2005) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.20512 · Cited by 328
Luechtefeld, T., Marsh, D., Rowlands, C., & Hartung, T. (2018) · Toxicological Sciences · doi:10.1093/toxsci/kfy152 · Cited by 327
AI in drug discovery and its clinical relevance
Qureshi, R., Irfan, M., Gondal, T. M., Khan, S., Wu, J., Hadi, M. U., Heymach, J., Le, X., Yan, H., & Alam, T. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e17575 · Cited by 319 · cited 1×
“Furthermore, corroborating experimental findings with computational predictions strengthens the credibility and translational viability of the drug discovery process, marking a significant advancement in this field 16,27 (Figure 2).”
ResultMetz, J. T., Johnson, E. F., Soni, N. B., Merta, P. J., Kifle, L., & Hajduk, P. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.530 · Cited by 311
Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide
Tamargo, J., Le Heuzey, J.-Y., & Mabo, P. (2015) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-015-1832-0 · Cited by 276 · cited 1×
“11 Only 43 − 63% of toxicity predictions using rodent and nonrodent models match when extrapolated to humans and less than 30% when predicting adverse drug effects in target organs.”
BackgroundMONN: A Multi-objective Neural Network for Predicting Compound-Protein Interactions and Affinities
Li, S., Wan, F., Shu, H., Jiang, T., Zhao, D., & Zeng, J. (2020) · Cell Systems · doi:10.1016/j.cels.2020.03.002 · Cited by 248
Longato, E., Vettoretti, M., & Di Camillo, B. (2020) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2020.103496 · Cited by 228
Huang, R., Xia, M., Nguyen, D.-T., Zhao, T., Sakamuru, S., Zhao, J., Shahane, S. A., Rossoshek, A., & Simeonov, A. (2016) · Frontiers in Environmental Science · doi:10.3389/fenvs.2015.00085 · Cited by 227
Tran, T. T. V., Surya Wibowo, A., Tayara, H., & Chong, K. T. (2023) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.3c00200 · Cited by 226
Self-Attention Based Molecule Representation for Predicting Drug-Target InteractionPreprint
Shin, B., Park, S. S., Kang, K., & Ho, J. C. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1908.06760 · Cited by 218
Deep Learning-Based Prediction of Drug-Induced Cardiotoxicity
Cai, C., Guo, P., Zhou, Y., Zhou, J., Wang, Q., Zhang, F., Fang, J., & Cheng, F. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00769 · Cited by 217 · cited 1×
“Beginning in 2019, a multitask DNN (MT DNN)-based model, deephERG, 59 was published to predict the hERG blocker activity for small molecules.”
MethodMachine Learning Toxicity Prediction: Latest Advances by Toxicity End Point
Cavasotto, C. N., & Scardino, V. (2022) · ACS Omega · doi:10.1021/acsomega.2c05693 · Cited by 213
Machine learning models for drug–target interactions: current knowledge and future directions
D’Souza, S., Prema, K. V., & Balaji, S. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.03.003 · Cited by 206
SAR and QSAR modeling of a large collection of LD50 rat acute oral toxicity data
Gadaleta, D., Vuković, K., Toma, C., Lavado, G. J., Karmaus, A. L., Mansouri, K., Kleinstreuer, N. C., Benfenati, E., & Roncaglioni, A. (2019) · Journal of Cheminformatics · doi:10.1186/s13321-019-0383-2 · Cited by 199
Machine learning and artificial intelligence in physiologically based pharmacokinetic modeling
Chou, W.-C., & Lin, Z. (2023) · Toxicological Sciences · doi:10.1093/toxsci/kfac101 · Cited by 190
An Overview of Machine Learning and Big Data for Drug Toxicity Evaluation
Vo, A. H., Van Vleet, T. R., Gupta, R. R., Liguori, M. J., & Rao, M. S. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00227 · Cited by 188 · cited 2×
“10,18 For example, according to Luechte-feld’s findings, 20 contemporary methodologies that integrate QSAR with artificial intelligence have proven highly effective in categorizing compounds across 19 different hazard categories, employing 74 labels as target features.”
BackgroundGrulke, C. M., Williams, A. J., Thillanadarajah, I., & Richard, A. M. (2019) · Computational Toxicology · doi:10.1016/j.comtox.2019.100096 · Cited by 179
On-target and Off-target-based Toxicologic Effects
Rudmann, D. G. (2012) · Toxicologic Pathology · doi:10.1177/0192623312464311 · Cited by 176
Singh, A. V., Varma, M., Laux, P., Choudhary, S., Datusalia, A. K., Gupta, N., Luch, A., Gandhi, A., Kulkarni, P., & Nath, B. (2023) · Archives of Toxicology · doi:10.1007/s00204-023-03471-x · Cited by 169
Activity, assay and target data curation and quality in the ChEMBL database
Papadatos, G., Gaulton, A., Hersey, A., & Overington, J. P. (2015) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-015-9860-5 · Cited by 168
The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies
Mattingly, C. J., Rosenstein, M. C., Colby, G. T., Forrest Jr, J. N., & Boyer, J. L. (2006) · Journal of Experimental Zoology Part A: Comparative Experimental Biology · doi:10.1002/jez.a.307 · Cited by 161
Toxicity prediction based on artificial intelligence: A multidisciplinary overview
Pérez Santín, E., Rodríguez Solana, R., González García, M., García Suárez, M. D. M., Blanco Díaz, G. D., Cima Cabal, M. D., Moreno Rojas, J. M., & López Sánchez, J. I. (2021) · WIREs Computational Molecular Science · doi:10.1002/wcms.1516 · Cited by 153
Waters, M., Stasiewicz, S., Alex Merrick, B., Tomer, K., Bushel, P., Paules, R., Stegman, N., Nehls, G., Yost, K. J., Johnson, C. H., et al. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm755 · Cited by 149
WideDTA: prediction of drug-target binding affinity
Öztürk, H., Özkırımlı, E., & Özgür, A. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1902.04166 · Cited by 148
FP-ADMET: a compendium of fingerprint-based ADMET prediction models
Venkatraman, V. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00557-5 · Cited by 148
Comparison Study of Computational Prediction Tools for Drug-Target Binding Affinities
Thafar, M., Raies, A. B., Albaradei, S., Essack, M., & Bajic, V. B. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00782 · Cited by 144
Sharma, B., Chenthamarakshan, V., Dhurandhar, A., Pereira, S., Hendler, J., Dordick, J. S., & Das, P. (2023) · Scientific Reports · doi:10.1038/s41598-023-31169-8 · Cited by 144
The Coefficient of Determination: What Determines a Useful R 2 Statistic?
Saunders, L. J., Russell, R. A., & Crabb, D. P. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10598 · Cited by 136
Atkins, J. T., George, G. C., Hess, K., Marcelo-Lewis, K. L., Yuan, Y., Borthakur, G., Khozin, S., LoRusso, P., & Hong, D. S. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01033-x · Cited by 132
GANsDTA: Predicting Drug-Target Binding Affinity Using GANs
Zhao, L., Wang, J., Pang, L., Liu, Y., & Zhang, J. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2019.01243 · Cited by 131
DeepHIT: a deep learning framework for prediction of hERG-induced cardiotoxicity
Ryu, J. Y., Lee, M. Y., Lee, J. H., Lee, B. H., & Oh, K. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa075 · Cited by 131
Jain, S., Siramshetty, V. B., Alves, V. M., Muratov, E. N., Kleinstreuer, N., Tropsha, A., Nicklaus, M. C., Simeonov, A. M., & Zakharov, A. V. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.0c01164 · Cited by 125 · cited 1×
“As a significant advancement in toxicology research, Jain et al. (2021) addressed the challenge of predicting compound toxicity across various exposure routes and species.”
BackgroundNovel Computational Approach to Predict Off-Target Interactions for Small Molecules
Rao, M. S., Gupta, R., Liguori, M. J., Hu, M., Huang, X., Mantena, S. R., Mittelstadt, S. W., Blomme, E. A. G., & Van Vleet, T. R. (2019) · Frontiers in Big Data · doi:10.3389/fdata.2019.00025 · Cited by 118
Recommended criteria for the evaluation of bacterial mutagenicity data (Ames test)
Levy, D. D., Zeiger, E., Escobar, P. A., Hakura, A., van der Leede, B. M., Kato, M., Moore, M. M., & Sugiyama, K. (2019) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2019.07.004 · Cited by 111
Deep drug-target binding affinity prediction with multiple attention blocks
Zeng, Y., Chen, X., Luo, Y., Li, X., & Peng, D. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab117 · Cited by 110
Wei, Y., Li, S., Li, Z., Ziwei, W., & Lin, J. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac192 · Cited by 104 · cited 1×
“ADMETLAB2, 48 FP-ADMET, 49 Interpretable ADMET, 22 and HelixAMDET 23 are general methods used to predict several ADMET end points.”
MethodProteomics Applications in Health: Biomarker and Drug Discovery and Food Industry.
Dashatan, N. A., Koushki, M., Abbaszadeh, H., Rostami‐Nejad, M., & Rezaei–Tavirani, M. (2018) · PubMed Central · Cited by 102
Comparative Study of Multitask Toxicity Modeling on a Broad Chemical Space
Sosnin, S., Karlov, D., Tetko, I. V., & Fedorov, M. V. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.8b00685 · Cited by 102
ResNet18DNN: prediction approach of drug-induced liver injury by deep neural network with ResNet18
Chen, Z., Jiang, Y., Zhang, X., Zheng, R., Qiu, R., Sun, Y., Zhao, C., & Shang, H. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab503 · Cited by 102
Karim, A., Lee, M., Balle, T., & Sattar, A. (2021) · Journal of Cheminformatics · doi:10.1186/s13321-021-00541-z · Cited by 99
Application of proteomic technologies in the drug development process
Walgren, J. L., & Thompson, D. C. (2004) · Toxicology Letters · doi:10.1016/j.toxlet.2003.12.047 · Cited by 92
Li, Y., Wang, Z., Li, Y., Du, J., Gao, X., Li, Y., & Lai, L. (2024) · Pharmaceutical Research · doi:10.1007/s11095-024-03725-y · Cited by 92
An integrative machine learning approach for prediction of toxicity-related drug safety
Lysenko, A., Sharma, A., Boroevich, K. A., & Tsunoda, T. (2018) · Life Science Alliance · doi:10.26508/lsa.201800098 · Cited by 88
Smith, R. D., Clark, J. J., Ahmed, A., Orban, Z. J., Dunbar, J. B., & Carlson, H. A. (2019) · Journal of Molecular Biology · doi:10.1016/j.jmb.2019.05.024 · Cited by 87
Danishuddin, M., Kumar, V., Faheem, M., & Lee, K. W. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.09.013 · Cited by 86
Thafar, M. A., Alshahrani, M., Albaradei, S., Gojobori, T., Essack, M., & Gao, X. (2022) · Scientific Reports · doi:10.1038/s41598-022-08787-9 · Cited by 85
HergSPred: Accurate Classification of hERG Blockers/Nonblockers with Machine-Learning Models
Zhang, X., Mao, J., Wei, M., Qi, Y., & Zhang, J. Z. H. (2022) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.2c00256 · Cited by 80
Proteomics in Drug Development: The Dawn of a New Era?
Frantzi, M., Latosińska, A., & Mischak, H. (2019) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201800087 · Cited by 79
Choi, G.-W., Lee, Y.-B., & Cho, H.-Y. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11040168 · Cited by 79
Sequence-based drug-target affinity prediction using weighted graph neural networks
Jiang, M., Wang, S., Zhang, S., Zhou, W., Zhang, Y., & Li, Z. (2022) · BMC Genomics · doi:10.1186/s12864-022-08648-9 · Cited by 79
Artificial intelligence for compound pharmacokinetics prediction
Obrezanova, O. (2023) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2023.102546 · Cited by 74
Enhanced Graph Isomorphism Network for Molecular ADMET Properties Prediction
Peng, Y., Lin, Y., Jing, X., Zhang, H., Yi-ran, H., & Luo, G. S. (2020) · IEEE Access · doi:10.1109/access.2020.3022850 · Cited by 72
Nguyen‐Vo, T., Nguyen, L., Do, N., Le, P. H., Nguyen, T.-N., Nguyen, B. P., & Le, L. (2020) · ACS Omega · doi:10.1021/acsomega.0c03866 · Cited by 70
Chou, W.-C., & Lin, Z. (2020) · Environment International · doi:10.1016/j.envint.2020.105581 · Cited by 68
Joo, M., Park, A., Kim, K., Son, W., Lee, H. S., Lim, G., Lee, J., Lee, D. H., An, J., Kim, J. H., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20246276 · Cited by 67 · cited 1×
“90 − 92 Furthermore, they involve graphs, 93,94 ML algorithms, 90,95 DL, 77,96,97 or a combination of both.”
DeepCarc: Deep Learning-Powered Carcinogenicity Prediction Using Model-Level Representation
Li, T., Tong, W., Roberts, R. A., Liu, Z., & Thakkar, S. (2021) · Frontiers in Artificial Intelligence · doi:10.3389/frai.2021.757780 · Cited by 67
Preto, A. J., Matos‐Filipe, P., Mourão, J., & Moreira, I. S. (2022) · GigaScience · doi:10.1093/gigascience/giac087 · Cited by 63
Self-citationEquivariant Graph Neural Networks for Toxicity Prediction
Cremer, J., Medrano Sandonas, L., Tkatchenko, A., Clevert, D.-A., & De Fabritiis, G. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00032 · Cited by 62
Zhang, S., Yan, Z., Huang, Y., Liu, L., He, D., Wang, W., Fang, X., Zhang, X., Wang, F., Wu, H., et al. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac342 · Cited by 60 · cited 1×
“ADMETLAB2, 48 FP-ADMET, 49 Interpretable ADMET, 22 and HelixAMDET 23 are general methods used to predict several ADMET end points.”
MethodPearsons eller Spearmans korrelasjonskoeffisienter
Pripp, A. H. (2018) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.18.0042 · Cited by 56
Using chemical and biological data to predict drug toxicity
Liu, A., Seal, S., Yang, H., & Bender, A. (2023) · SLAS Discovery · doi:10.1016/j.slasd.2022.12.003 · Cited by 54
DeepTox: Toxicity prediction using deep learning
Klambauer, G., Unterthiner, T., Mayr, A., & Hochreiter, S. (2017) · Toxicology Letters · doi:10.1016/j.toxlet.2017.07.175 · Cited by 49
AI/ML Models to Predict the Severity of Drug-Induced Liver Injury for Small Molecules
Rao, M. S., Nassiri, V., Alhambra, C., Snoeys, J., Goethem, F. V., Irrechukwu, O., Aleo, M. D., Geys, H., Mitra, K., & Will, Y. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.3c00098 · Cited by 47
ADMET property prediction via multi-task graph learning under adaptive auxiliary task selection
Du, B.-X., Xu, Y., Yiu, S., Yu, H., & Shi, J. (2023) · iScience · doi:10.1016/j.isci.2023.108285 · Cited by 45
Feng, C., Chen, H., Yuan, X., Sun, M., Chu, K., Liu, H., & Rui, M. (2019) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.9b00143 · Cited by 44
Computational Prediction of Drug-Target Interactions via Ensemble Learning
Ezzat, A., Wu, M., Li, X., & Kwoh, C.-K. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8955-3_14 · Cited by 39 · cited 1×
“95,98 In general, these models can be classified as feature-or similarity-based; 96,99 however, ensemble techniques can include both procedures.”
BackgroundA graph neural network approach for molecule carcinogenicity prediction
Fradkin, P., Young, A., Atanackovic, L., Frey, B. J., Lee, L. J., & Wang, B. (2022) · Bioinformatics · doi:10.1093/bioinformatics/btac266 · Cited by 38 · cited 1×
“Therefore, to overcome the data-size challenge, CONCERTO by Fradkin et al. 63 was developed as a multiround pretraining methodology that uses mutagenic data to enhance the accuracy of the carcinogenicity task.”
MethodToxRefDB v2.1: update to curated in vivo study data in the Toxicity Reference Database
Feshuk, M., Kolaczkowski, L., Watford, S., & Friedman, K. P. (2023) · Frontiers in Toxicology · doi:10.3389/ftox.2023.1260305 · Cited by 38
Bueschbell, B., Caniceiro, A. B., Suzano, P. M. S., Machuqueiro, M., Rosário-Ferreira, N., & Moreira, I. S. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100811 · Cited by 37
Self-citationPredicting hERG channel blockers with directed message passing neural networks
Shan, M., Chen, J., Chen, J., Qin, L., Qin, J., & Cheng, G. (2022) · RSC Advances · doi:10.1039/d1ra07956e · Cited by 35
ToxCast EPA in Vitro to in Vivo Challenge: Insight into the Rank-I Model
Novotarskyi, S., Abdelaziz, A., Sushko, Y., Körner, R., Vogt, J., & Tetko, I. V. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.5b00481 · Cited by 34
A deep neural network–based approach for prediction of mutagenicity of compounds
Kumar, R., Khan, F. U., Sharma, A., Siddiqui, M. H., Aziz, I. A., Kamal, M. A., Ashraf, G. M., Alghamdi, B. S. A., & Uddin, M. S. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-14028-9 · Cited by 32
Protein Structure, Modelling and Applications
Breda, A., Valadares, N. F., de Souza, O. N., & Garratt, R. C. (2007) · Cited by 31
Artificial Intelligence–Enabled De Novo Design of Novel Compounds that Are Synthesizable
Bhisetti, G., & Fang, C. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_17 · Cited by 30 · cited 1×
“16,17 Furthermore, AI is highly useful for drug repurposing to identify new therapeutic targets.”
BackgroundMartin, S. A., McLanahan, E. D., Bushnell, P. J., Hunter, E. S., & El-Masri, H. A. (2014) · Toxicological Sciences · doi:10.1093/toxsci/kfu246 · Cited by 29
Big Data in Predictive Toxicology: Challenges, Opportunities and Perspectives
Richarz, A.-N. (2019) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623656-00001 · Cited by 29
Multiple toxicity endpoint–structure relationships for substituted phenols and anilines
Yan, F., Liu, T., Jia, Q., & Wang, Q. (2019) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2019.01.362 · Cited by 28 · cited 1×
“10,12,28 Indeed, models benefit from utilizing well-established end points, which facilitate the incorporation of vast data sets with valuable information across different species, from rodents to humans.”
BackgroundRyu, J. Y., Jang, W. D., Jang, J., & Oh, K. (2023) · BMC Bioinformatics · doi:10.1186/s12859-023-05176-5 · Cited by 28
Gadaleta, D., Marzo, M., Toropov, A. A., Toropova, A. P., Lavado, G. J., Escher, S. E., Dorne, J. L. C. M., & Benfenati, E. (2020) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.0c00176 · Cited by 27
Mavroudis, P. D., Teutonico, D., Abós, A., & Pillai, N. (2023) · Frontiers in Systems Biology · doi:10.3389/fsysb.2023.1180948 · Cited by 27
Assessment of Drug-Induced Liver Injury through Cell Morphology and Gene Expression Analysis
Lejal, V., Cerisier, N., Rouquié, D., & Taboureau, O. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00381 · Cited by 27
Li, T., Liu, Z., Thakkar, S., Roberts, R. A., & Tong, W. (2023) · Regulatory Toxicology and Pharmacology · doi:10.1016/j.yrtph.2023.105486 · Cited by 27
Chua, H. E., Bhowmick, S. S., & Tucker‐Kellogg, L. (2017) · Methods · doi:10.1016/j.ymeth.2017.05.015 · Cited by 26
Deng, L., Zeng, Y., Liu, H., Liu, Z., & Liu, X. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44050155 · Cited by 26
Predicting Chemical Carcinogens Using a Hybrid Neural Network Deep Learning Method
Limbu, S., & Dakshanamurthy, S. (2022) · Sensors · doi:10.3390/s22218185 · Cited by 24
Toxicity prediction using target, interactome, and pathway profiles as descriptors
Füzi, B., Mathai, N., Kirchmair, J., & Ecker, G. F. (2023) · Toxicology Letters · doi:10.1016/j.toxlet.2023.04.005 · Cited by 24
Mechanistic Task Groupings Enhance Multitask Deep Learning of Strain-Specific Ames Mutagenicity
Lui, R., Guan, D., & Matthews, S. T. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00385 · Cited by 21
Multiple Instance Learning Improves Ames Mutagenicity Prediction for Problematic Molecular Species
Feeney, S. V., Lui, R., Guan, D., & Matthews, S. T. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00372 · Cited by 20
Physiological factors affecting drug toxicity
Bailey, K. (1983) · Regulatory Toxicology and Pharmacology · doi:10.1016/0273-2300(83)90009-0 · Cited by 18
Drug-Target Binding Affinity Prediction Using TransformersPreprint
Saadat, M., Behjati, A., Zare‐Mirakabad, F., & Gharaghani, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.30.462610 · Cited by 18 · cited 1×
“100 The data used in these methods are generally retrieved from public databases or data sets.”
MethodDi, L., & Kerns, E. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801076-1.00019-8 · Cited by 16
Moein, M., Heinonen, M., Mesens, N., Chamanza, R., Amuzie, C. J., Will, Y., Ceulemans, H., Kaski, S., & Herman, D. (2023) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.2c00378 · Cited by 14
Nagarajan, M., Maadurshni, G. B., & Manivannan, J. (2021) · Journal of Toxicology and Environmental Health · doi:10.1080/15287394.2021.1994492 · Cited by 12
DrugTax: package for drug taxonomy identification and explainable feature extraction
Preto, A. J., Correia, P. C., & Moreira, I. S. (2022) · Journal of Cheminformatics · doi:10.1186/s13321-022-00649-w · Cited by 11
Self-citationCatozzi, S., Hill, R. J. W., Li, X., Dulong, S., Collard, E., & Ballesta, A. (2022) · CPT Pharmacometrics & Systems Pharmacology · doi:10.1002/psp4.12895 · Cited by 11
Benefits of Property Assessment and Good Drug-Like Properties
Di, L., & Kerns, E. H. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801076-1.00002-2 · Cited by 8
Drug-Target Indication Prediction by Integrating End-To-End Learning And Fingerprints
AGYEMANG, B., WU, W.-P., KPIEBAAREH, M. Y., & NANOR, E. (2019) · International Computer Conference on Wavelet Active Media Technology and Information Processing (ICCWAMTIP) · doi:10.1109/iccwamtip47768.2019.9067510 · Cited by 7
Piochi, L. F., Preto, A. J., & Moreira, I. S. (2023) · Bioinformatics · doi:10.1093/bioinformatics/btad645 · Cited by 7
Self-citationHellsten, K., Suchanova, B., Sihvola, V., Simanainen, U., Leppäranta, O., Chronis, K., Simon, D., & Bichlmaier, I. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100402 · Cited by 6
Li, Y., Wang, Z., Li, Y., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.07.17.549292 · Cited by 6
Li, Z., Wang, Y., Xie, Y. X., Zhang, L., Dai, Z., & Zou, X. (2018) · Analytical Methods · doi:10.1039/c8ay01396a · Cited by 5 · cited 1×
“95,98 In general, these models can be classified as feature-or similarity-based; 96,99 however, ensemble techniques can include both procedures.”
BackgroundWitkowski, J., Polak, S., Pawelec, D., & Rogulski, Z. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032239 · Cited by 3 · cited 1×
“138 Furthermore, such methodologies contribute to the implementation of the 3Rs (replacement, reduction, and refinement).”
MethodLalonde, R. L. (2009) · Elsevier eBooks · doi:10.1016/b978-1-4160-3291-5.50018-4 · Cited by 2
Research works printed but not linked: 1
- Feng Q.; Dueva E.; Cherkasov A.; Ester M. PADME: A Deep Learning-Based Framework for Drug-Target Interaction Prediction. arXiv [cs.LG], 2018.
Cited by
Artificial intelligence revolution in drug discovery: A paradigm shift in pharmaceutical innovation
Jarallah, S. J., Almughem, F. A., Alhumaid, N. K., Fayez, N. A., Alradwan, I. A., Alsulami, K. A., Tawfik, E. A., & Alshehri, A. A. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125789 · Cited by 93
Artificial intelligence (AI) in drug design and discovery: A comprehensive review
Bhat, A. R., & Ahmed, S. (2025) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2025.100049 · Cited by 76
Sohn, A., Park, J., Kim, W., Yoon, Y., Lee, S., Ji, J., & Kim, H. (2024) · Toxics · doi:10.3390/toxics12110822 · Cited by 68
“These developments collectively lead to a more efficient and ethical strategy in drug development, reducing the probability of late-stage failures caused by unanticipated toxicity [2,5,49,82,87].”
Overcoming Barriers in Cancer Biology Research: Current Limitations and Solutions
(2025) · doi:10.3390/cancers17132102 · Cited by 44
“However, they may not always accurately predict drug responses in humans because of species-specific differences in pharmacology and safety, and their generation and maintenance can be time-consuming and expensive [13–15].”
AI in fungal drug development: opportunities, challenges, and future outlook
Li, Y., Qiao, Y., Ma, Y., Xue, P., & Ding, C. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1610743 · Cited by 42
Metadata
- Authors
- Amorim, A. M. B., Piochi, L. F., Gaspar, A. T., Preto, A. J., Rosário-Ferreira, N., & Moreira, I. S.
- Affiliations
- Centro de Neurociências e Biologia Celular (PT)
- CNC-UC─Center for Neuroscience and Cell Biology, University of Coimbra, Calçada Martim de Freitas, 3000-456 Coimbra, Portugal
- Corresponding author
- Moreira, Irina S.
- Venue
- Chemical Research in Toxicology
- Publisher
- American Chemical Society (ACS)
- Published
- 2024-05-17
- Volume
- 37
- Issue
- 6
- Pages
- 827-849
- ISSN
- 0893-228X (ISSN-L)
- 1520-5010
- PMC
- PMC11187637
- OpenAlex
- W4397001794
- Cited by
- 132
- References
- 140
- Citations by year
- 2026: 69 · 2025: 56 · 2024: 7
- FWCI
- 3.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Chemical Research in Toxicology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- European Regional Development Fund
- Funda??o para a Ci?ncia e a Tecnologia (DSAIPA/DS/0118/2020, LA/P/0058/2020, SFRH/BD/144966/2019, UIDB/04539/2020, UIDP/04539/2020)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Veterinary › Small Animals › Animal testing and alternatives
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- drug toxicity prediction, drug safety, drug development attrition, protein-ligand interactions, drug binding affinity, off-target effects, computational toxicology, 3Rs, preclinical toxicity testing
- MeSH terms
- Drug Development, Animals, Humans, Drug-Related Side Effects and Adverse Reactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.